Abstract
Ambulatory blood pressure (BP) monitoring provides valuable information on a person’s BP phenotype. Abnormal ambulatory BP phenotypes include white-coat hypertension, masked hypertension, nocturnal nondipping, nocturnal hypertension, and high BP variability. Compared to people with sustained normotension (normal BP in the clinic and on ambulatory BP monitoring), the limited research available suggests that the risk of developing sustained hypertension (abnormal BP in the clinic and on ambulatory BP monitoring) over 5 to 10 years is approximately two to three times greater for people with white-coat or masked hypertension. More limited data suggest that nondipping might predate hypertension, and no studies, to our knowledge, have examined whether nocturnal hypertension or high ambulatory BP variability predict hypertension. Ambulatory BP monitoring may be useful in identifying people at increased risk of developing sustained hypertension, but the clinical utility for such use would need to be further examined.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410. doi:10.1161/01.cir.0000442015.53336.12. Presents the most recent statistics on cardiovascular disease including the contributions of hypertension.
Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the Multi-ethnic Study of Atherosclerosis. Hypertension. 2011;57:1101–7.
Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287(8):1003–10.
Whelton PK, He J, Appel LJ, National High Blood Pressure Education Program Coordinating Committee, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882–8.
Sacks FM, Svetkey LP, Vollmer WM, DASH-Sodium Collaborative Research Group, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3–10.
Chobanian AV, Bakris GL, Black HR, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.
Viera AJ, Lingley K, Esserman D. Effects of labeling patients as prehypertensive. J Am Board Fam Med. 2010;23(5):571–83.
Viera AJ, Bangura F, Mitchell CM, Cerna A, Sloane P. Do clinicians tell patients they have prehypertension? J Am Board Fam Med. 2011;24(1):117–8.
Spruill TM, Feltheimer SD, Harlapur M, et al. Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life. J Psychosom Res. 2013;74(5):433–8.
Echouffo-Tcheugui JB, Batty GD, Kivimäki M, Kengne AP. Risk models to predict hypertension: a systematic review. PLoS ONE. 2013;8(7):e67370. This article provides a review of the available hypertension risk models and scores.
Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med. 2006;354:2368–74.
O’Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68. doi:10.1097/HJH.0b013e328363e964. Presents comprehensive, up-to-date information on all aspects of ambulatory blood pressure monitoring.
Pierdomenico SD, Di Nicola M, Esposito AL, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22(8):842–7.
Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54(2):226–32. This article provides some of the leading evidence of the risk of sustained hypertension for people with white-coat and masked hypertension.
Ugajin T, Hozawa A, Okhubo T, et al. White-coat hypertension as a risk factor for the development of home hypertension. Arch Intern Med. 2005;165:1541–6.
Trudel X, Milot A, Brisson C. Persistence and progression of masked hypertension: a 5-year prospective study. Int J Hypertens. 2013;2013:836387. doi:10.1155/2013/836387. This article examines what happens to blood pressure in people identified with masked hypertension 5 years later.
Pierdomenico SD, Pannarale G, Rabbia F, et al. Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens. 2008;21(8):879–83.
Viera AJ, Zhu S, Hinderliter AL, Shimbo D, Person SD, Jacobs Jr DR. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hypertens. 2011;5(1):48–55.
Li Y, Wang J. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61:278–83.
Tsioufis C, Andrikou I, Thomopoulos C, Syrseloudis D, Stergiou G, Stefanadis C. Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. J Hum Hypertens. 2011;25:281–93.
Mena L, Pintos S, Queipo NV, Jaizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11.
Stolarz-Skrzypek K, Thijs L, Li Y, et al. Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO). Acta Cardiol. 2011;66(6):701–6.
Yamaguchi Y, Wada M, Sato H, et al. Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese. Am J Hypertens. 2014. A recent study of the association of ambulatory blood pressure variability with cognitive outcomes.
Verberk WJ, Kessesl AG, de Leeuw PW. Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens. 2008;21:969–75.
Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.
Brguljan-Hitij J, Thijs L, Li Y, Hansen TW, on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcome Investigators, et al. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014. Uses the large IDACO database to examine outcomes across different BP phenotypes.
Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–15.
Viera AJ, Lin FC, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, et al. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014.
Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. doi:10.1136/bmj.d4891.
Compliance with Ethics Guidelines
Conflict of Interest
Anthony Viera has served on the medical advisory board for Suntech Medical, manufacturer of a brand of ambulatory blood pressure monitor, as well as the hypertension advisory board for Daiichi-Sankyo.
Daichi Shimbo declares that he has no conflict of interest.
This article was partially supported by grants R01-HL098604 (Dr. Viera) and P01-HL047540 (Dr. Shimbo) from the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH).
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Prevention of Hypertension: Public Health Challenges
Rights and permissions
About this article
Cite this article
Viera, A.J., Shimbo, D. Ambulatory Blood Pressure Phenotypes and the Risk for Hypertension. Curr Hypertens Rep 16, 481 (2014). https://doi.org/10.1007/s11906-014-0481-5
Published:
DOI: https://doi.org/10.1007/s11906-014-0481-5